Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology crawled time : 10:00 save search
Biohaven Announces Pricing of $230 Million Public Offering of Common Shares
Published: 2024-04-18 (Crawled : 10:00) - prnewswire.com
MS | News 0 d | $90.26 0.2% 0.0% 6.7M
|
Finance
|
| O: 0.43%
H: 0.0%
C: 0.0%
BHVN | News 0 d | $42.16 -4.25% 0.85% 3.7M
|
Health Technology
|
| O: -2.19%
H: 0.96%
C: -1.72%
million offering
Viral Vector and Plasmid DNA Technologies: A Global Market Perspective
Published: 2024-04-17 (Crawled : 10:00) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M
|
Health Technology
|
| O: -0.26%
H: 0.03%
C: -1.55%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.87%
H: 0.16%
C: -0.59%
RGNX | $16.08 -5.58% -5.91% 560K
|
Health Technology
|
| O: -1.43%
H: 2.27%
C: -3.18%
global dna market
Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024
Published: 2024-04-15 (Crawled : 10:00) - ir.auriniapharma.com
AUPH | $4.81 -2.04% -2.08% 2.1M
|
Health Technology
|
| O: 1.39%
H: 2.67%
C: -0.98%
first pharmaceuticals financial results
Immuron to host Live Virtual Event
Published: 2024-04-15 (Crawled : 10:00) - globenewswire.com
IMRN | $2.41 -9.28% 9.6K
|
Health Technology
|
| O: 3.4%
H: 0.0%
C: -5.47%
Oncocyte Reports Full Year 2023 Financial Results
Published: 2024-04-12 (Crawled : 10:00) - globenewswire.com
BIO | News | $281.02 -3.38% -0.36% 370K
|
Health Technology
|
| O: -5.2%
H: 0.24%
C: -2.79%
OCX J | $2.52 -2.7% -2.78% 37K
|
Health Technology
|
| O: 7.93%
H: 3.12%
C: -15.31%
year financial results
The Gross Law Firm Notifies Snowflake Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - SNOW
Published: 2024-04-12 (Crawled : 10:00) - prnewswire.com
SNOW | $148.41 -0.26% -0.04% 3.8M
|
Technology Services
|
| O: 1.23%
H: 2.18%
C: 0.93%
LTRX | News | $3.15 1.29% 1.27% 130K
|
Distribution Services
|
| O: 1.04%
H: 0.0%
C: 0.0%
AVXL | $3.8 -6.63% -7.11% 1.7M
|
Health Technology
|
| O: 3.48%
H: 0.0%
C: 0.0%
deadline
Class Action Filed Against Innodata Inc. (INOD) Seeking Recovery for Investors - Contact The Gross Law Firm
Published: 2024-04-12 (Crawled : 10:00) - prnewswire.com
LTRX | News | $3.15 1.29% 1.27% 130K
|
Distribution Services
|
| O: 1.04%
H: 0.0%
C: 0.0%
INOD | $5.87 -0.68% -0.68% 220K
|
Technology Services
|
| O: -0.31%
H: 0.0%
C: 0.0%
AVXL | $3.8 -6.63% -7.11% 1.7M
|
Health Technology
|
| O: 3.48%
H: 0.0%
C: 0.0%
for
The Gross Law Firm Notifies Amplitude, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - AMPL
Published: 2024-04-12 (Crawled : 10:00) - prnewswire.com
AMPL | $9.47 -0.21% -0.21% 300K
|
|
| O: -0.44%
H: 0.0%
C: 0.0%
LTRX | News | $3.15 1.29% 1.27% 130K
|
Distribution Services
|
| O: 1.04%
H: 0.0%
C: 0.0%
AVXL | $3.8 -6.63% -7.11% 1.7M
|
Health Technology
|
| O: 3.48%
H: 0.0%
C: 0.0%
deadline
Shareholders of Shoals Technologies Group, Inc. Should Contact The Gross Law Firm Before May 21, 2024 to Discuss Your Rights - SHLS
Published: 2024-04-12 (Crawled : 10:00) - prnewswire.com
SHLS | $8.22 -0.73% -0.73% 3.3M
|
|
| O: -4.76%
H: 0.0%
C: 0.0%
LTRX | News | $3.15 1.29% 1.27% 130K
|
Distribution Services
|
| O: 1.04%
H: 0.0%
C: 0.0%
AVXL | $3.8 -6.63% -7.11% 1.7M
|
Health Technology
|
| O: 3.48%
H: 0.0%
C: 0.0%
shoals
Class Action Filed Against agilon health, inc. (AGL) Seeking Recovery for Investors - Contact The Gross Law Firm
Published: 2024-04-12 (Crawled : 10:00) - prnewswire.com
LTRX | News | $3.15 1.29% 1.27% 130K
|
Distribution Services
|
| O: 1.04%
H: 0.0%
C: 0.0%
AVXL | $3.8 -6.63% -7.11% 1.7M
|
Health Technology
|
| O: 3.48%
H: 0.0%
C: 0.0%
for
Exploring New Horizons: BCC Research Forecasts $5.2 Billion Global Induced Pluripotent Stem Cells Market by 2028
Published: 2024-04-12 (Crawled : 10:00) - prnewswire.com
TMO | News | $541.52 -1.05% 0.61% 2.1M
|
Health Technology
|
| O: -1.18%
H: 0.0%
C: 0.0%
research global market
Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024
Published: 2024-04-11 (Crawled : 10:00) - globenewswire.com
ZYME | $8.68 -1.92% -1.96% 730K
|
Health Technology
|
| O: 0.77%
H: 2.61%
C: 1.96%
BGNE | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: -1.55%
H: 0.89%
C: -1.01%
first conference report financial results
West to Host First-Quarter 2024 Conference Call
Published: 2024-04-11 (Crawled : 10:00) - prnewswire.com
WST | $377.33 -0.01% 0.0% 320K
|
Health Technology
|
| O: 1.44%
H: 0.42%
C: -1.24%
conference west
BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule
Published: 2024-04-11 (Crawled : 10:00) - prnewswire.com
BCLI | $0.503 -6.99% -7.51% 1.1M
|
Health Technology
|
| O: -0.17%
H: 13.56%
C: -2.19%
nasdaq cell therapeutics market
BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS
Published: 2024-04-10 (Crawled : 10:00) - prnewswire.com
BCLI | $0.503 -6.99% -7.51% 1.1M
|
Health Technology
|
| O: -20.14%
H: 0.0%
C: 0.0%
als biomarker publication cell trial therapeutics
Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients with Multiple System Atrophy (MSA) on May 23, 2024
Published: 2024-04-10 (Crawled : 10:00) - prnewswire.com
TBPH | $9.22 -3.15% -3.25% 360K
|
Health Technology
|
| O: -1.37%
H: 2.14%
C: 2.03%
treatment system for key potential
Immuron Travelan® sales continued strong growth
Published: 2024-04-10 (Crawled : 10:00) - globenewswire.com
IMRN | $2.41 -9.28% 9.6K
|
Health Technology
|
| O: 7.08%
H: 4.75%
C: 1.36%
travelan sales growth
Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conference
Published: 2024-04-09 (Crawled : 10:00) - ir.auriniapharma.com
AUPH | $4.81 -2.04% -2.08% 2.1M
|
Health Technology
|
| O: -0.4%
H: 5.41%
C: 2.4%
conference
BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS
Published: 2024-04-09 (Crawled : 10:00) - prnewswire.com
BCLI | $0.503 -6.99% -7.51% 1.1M
|
Health Technology
|
| O: 10.45%
H: 0.0%
C: 0.0%
fda als cell for trial therapeutics agreement
Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting
Published: 2024-04-08 (Crawled : 10:00) - globenewswire.com
ZYME | $8.68 -1.92% -1.96% 730K
|
Health Technology
|
| O: 0.0%
H: 1.76%
C: -0.62%
BGNE | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: -0.94%
H: 1.12%
C: 0.61%
association cancer research preclinical for meeting
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.